| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |